Subcutaneous Immunoglobulin as Replacement Therapy of Children with Primary Immunodeficiencies

被引：0
|
作者：
Uglova, T. [1 ]
Aleshkevich, S. [1 ]
机构：
[1] Natl Res Ctr Pediat Oncol Hematol & Immunol, Minsk, BELARUS
来源：
JOURNAL OF CLINICAL IMMUNOLOGY | 2014年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
ESID-0356
引用
收藏
页码：S308 / S308
页数：1
相关论文
共 50 条
  • [1] Subcutaneous Immunoglobulin Replacement Therapy in Infants and Children with Primary Immunodeficiencies
    Church, J. A.
    Howard, V.
    Sleasman, J. W.
    Borte, M.
    Berger, M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB213 - AB213
  • [2] Subcutaneous immunoglobulin replacement in primary immunodeficiencies
    Berger, M
    CLINICAL IMMUNOLOGY, 2004, 112 (01) : 1 - 7
  • [3] Immunoglobulin replacement therapy for primary immunodeficiencies
    Peter, Jonathan G.
    Chapel, Helen
    IMMUNOTHERAPY, 2014, 6 (07) : 853 - 869
  • [4] Pharmacokinetics of subcutaneous immunoglobulin and their use in dosing of replacement therapy in patients with primary immunodeficiencies
    Berger, Melvin
    Rojavin, Mikhail
    Kiessling, Peter
    Zenker, Othmar
    CLINICAL IMMUNOLOGY, 2011, 139 (02) : 133 - 141
  • [5] Subcutaneous immunoglobulin replacement in patients with primary immunodeficiencies (PID) - Portuguese experience
    Faria, E.
    Lopes-Silva, S.
    Marques, L.
    Guedes, M.
    Goncalo-Marques, J.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2008, 154 : 103 - 104
  • [6] Home therapy with subcutaneous immunoglobulin infusions in children with congenital immunodeficiencies
    Abrahamsen, TG
    Sandersen, H
    Bustnes, A
    PEDIATRICS, 1996, 98 (06) : 1127 - 1131
  • [7] Efficacy and safety of home-based subcutaneous immunoglobulin replacement therapy in paediatric patients with primary immunodeficiencies
    Borte, M.
    Bernatowska, E.
    Ochs, H. D.
    Roifman, C. M.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2011, 164 (03): : 357 - 364
  • [8] Effectiveness, Safety, and Treatment Satisfaction of 20% Subcutaneous Immunoglobulin Replacement Therapy in Pediatric Patients with Primary and Secondary Immunodeficiencies
    Yildiz, Ceren Ayca
    Gokdemir, Yasemin
    Eralp, Ela Erdem
    Ergenekon, Pinar
    Karakoc, Fazilet
    Karadag, Bulent
    TURKISH ARCHIVES OF PEDIATRICS, 2025, 60 (02):
  • [9] Treatment of children with primary immunodeficiencies with a subcutaneous immunoglobulin 16.5% (cutaquig(R) [octanorm])
    Kobayashi, Roger H.
    Mandujano, Jose Fernando
    Rehman, Syed M.
    Kobayashi, Ai Lan
    Geng, Bob
    Atkinson, Thomas Prescott
    Melamed, Isaac
    Turpel-Kantor, Eva
    Clodi, Elisabeth
    Gupta, Sudhir
    IMMUNOTHERAPY, 2021, 13 (10) : 813 - 824
  • [10] Immunoglobulin Replacement Therapy in Primary Immunodeficiencies and Quality of Life-A Case Report
    Szynkiewicz, E.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 : S511 - S512
12345